financetom
Business
financetom
/
Business
/
Update: US Senate Panel Reportedly Focuses on Boeing's Quality Assurance Practices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: US Senate Panel Reportedly Focuses on Boeing's Quality Assurance Practices
Oct 3, 2024 1:21 AM

09:08 AM EDT, 09/25/2024 (MT Newswires) -- (Updates to add FAA statement in the fourth paragraph.)

Boeing's ( BA ) quality assurance practices are the focus as the US Senate Permanent Subcommittee on Investigations found the company's workers "continue to feel pressure to prioritize speed of production over quality," news outlets reported Wednesday, citing a memo from the Senate panel's Democratic Party staff members.

The Senate subcommittee is investigating Boeing's ( BA ) safety issues. The panel's memo noted gaps in the company's quality inspection procedures and how Boeing ( BA ) fails to ensure employees' adequate training for their tasks, multiple news outlets said. In addition, the Senate Permanent Subcommittee on Investigations found fault with the Federal Aviation Administration's oversight, given Boeing's ( BA ) recurring safety issues, according to the reports.

The memo was issued ahead of Federal Aviation Administration Administrator Michael Whitaker's scheduled testimony before the subcommittee Wednesday.

"The Administrator will address the issues at today's hearing," the FAA said in an emailed response to a request for comment from MT Newswires. Whitaker said that "this won't be back to business as usual for Boeing ( BA )," the FAA added.

Boeing ( BA ) did not immediately respond to MT Newswires' request for comments.

Price: 155.75, Change: -0.06, Percent Change: -0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Merck ( MRK ) said Thursday that it has initiated a pivotal phase 3 clinical trial evaluating zilovertamab vedotin, an investigational antibody-drug conjugate to treat patients with previously untreated diffuse large B-cell lymphoma. The company said the trial will combine zilovertamab vedotin with rituximab plus cyclophosphamide, doxorubicin and prednisone, compared with rituximab plus...
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care
Feb 6, 2025
Feb 6 (Reuters) - Lyft ( LYFT ) said on Thursday it has tied up with Amazon ( AMZN ) and Alphabet-backed startup Anthropic to roll out artificial intelligence tools for the ride-hailing platform's customer care operations. The company said it has been using Anthropic's Claude AI model, through Amazon's ( AMZN ) Bedrock generative AI platform, which has helped...
Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand
Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand
Feb 6, 2025
Feb 6 (Reuters) - Packaged food company Kellanova ( K ) beat Wall Street expectations for fourth-quarter earnings on Thursday, on the back of steady demand for its snacks and breakfast cereals such as Pringles and Cheez-It. While other packaged food companies such as Conagra and McCormick ( MKC ) are facing a demand slowdown as customers cut back on...
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease
Feb 6, 2025
09:04 AM EST, 02/06/2025 (MT Newswires) -- Sonos ( SONO ) reported fiscal Q1 non-GAAP net income Thursday of $0.64 per diluted share, down from $0.84 a year earlier. Three analysts polled by FactSet expected $0.30. Revenue for the fiscal quarter ended Dec. 28 was $550.9 million, down from $612.9 million a year earlier. Analysts surveyed by FactSet expected $519.8...
Copyright 2023-2026 - www.financetom.com All Rights Reserved